Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document

PUBLICATIONS 2005

 

734.      Anderassen CN, Alsner J, Overgaard J, Herskind C, Havilland J, Owen R, Holmwood J, Yarnold J: TGFB1 polymorphisms correlate with risk of late normal tissue complications after radiotherapy. Radiother. Oncol. 75: 18-21, 2005. Pubmed |PDF

735.      Bentzen, L., Vestergaard-Poulsen, P., Nielsen, T., Overgaard, J., Bjørnerud , A., Briley-Sæbø, K., Horsman, M.R. & Østergaard L.: Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. Int. J. Radiat. Oncol. Biol. Phys. 61: 108-1215, 2005. 

736.      Calin GA, Trapasso F, Shimizu M, Calin DD, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu C-G, Neuberg D, Bullrich F, Negrini M, & Croce CM: Familial Cancer Associated with A Polymorphism in ARLTS1N Engl J Med 352: 1667-1676, 2005. 

737.      Chen, G., Jespersen, S.N., Pedersen, M., Horsman, M.R. and Stødkilde-Jørgensen, H. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Mag. Reson. Imagaging. 23: 685-689, 2005. 

738.      Chen, G., Jespersen, S.N., Pedersen, M., Horsman, M.R. and Stødkilde-Jørgensen, H. Evaluation of anti-vascular therapy with texture analysis. Anticancer Res 25: 3399-3405, 2005Pubmed

739.      Eriksen JG, Alsner J, Steiniche T & Overgaard J: The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. Radiother. Oncol. 76: 135-142, 2005. 

740.      Eriksen, J.G., Steiniche, T. & Overgaard, J.: The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Acta Oncol. 44: 50-58, 2005. 

741.      Eriksen, J.G., Steiniche, T. & Overgaard, J.: The Epidermal growth factor receptor and tumor differentiation predicts the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck. Radiother. Oncol. 74: 93-100, 2005. 

742.      Johansen, L.V.: Carcinoma of the pharynx and larynx. A series of 1874 consecutive patients treated at Aarhus University Hospital. Dr. med. Thesis, Faculty of Health Science, University of Aarhus, 2005. 

743.      Isager, P., Ehlers, N. & Overgaard, J.: Survival after enucleation and radiation brachytherapy for choroidal and ciliary body melanomas (letter). Acta Ophthalmol. Scand. 83: 398-399, 2005. 

744.      Isager, P., Østerlind, A., Engholm, G., Heegaard, S., Lindegaard, J, Overgaard, J. & Storm H.H.: Uveal and conjunctival malignant melanoma in denmark, 1943-97: incidence and validation study. Ophthalmic Epidemiol. 12:223-32, 2005.

745.      Nielsen HM, Overgaard J, Grau C, Christensen JJ & Overgaard M: Audit of the radiotherapy in the DBCG 82 b&c trials – a validation study of the 1538 patients randomized to postmastectomy radiotherapy. Radiother. Oncol. 76: 285-292, 2005.

746.      Nordsmark, M., Bentzen, SM., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M, Molls, M., Dunst, J., Terris, DJ. & Overgaard, J.: Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother. Oncol. 77: 1-7, 2005. 

747.      Overgaard, J.: Radiotherapy and Oncology comes of age. Radiother. Oncol. 75: 1-5, 2005. 

748.      Overgaard J, van der Kogel A: ESTRO-Wolfsberg a Synergistic Approach towards Modern Radiobiology (Editorial). Radiother Oncol. 76: 109-111, 2005. 

749.      Lauridsen, M.C., Christiansen, P. & Hessov, I.: The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer - a randomized study. Acta Oncol. 44: 449-457, 2005. 

750.      Lundby L, Krogh K, Jensen VJ, Gandrup P, Qvist N, Overgaard J & Laurberg S.: Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis. Colon Rectum 48: 1343-1352, 2005. 

751.      Siemann DW, Bibby MC, Dark GG, Dicker AP, Eskens FA, Horsman MR, Marme D, Lorusso PM. Differentiation and definition of  vascular-targeted therapies. Clin Cancer Res. 11: 416-20, 2005. 

752.      Sørensen M., Horsman M.R., Cumming P., Munk O.L. and Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO and PET, autoradiography and electrode pO2 measurements in murine tumors. Int. J Radiation Oncology Biol. Phys. 62: 854-861, 2005. 

753.      Sørensen BS, Hao J, Overgaard J, Alsner J & Horsman MR: Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother. Oncol. 76: 187-193, 2005. 

754.      Overgaard J, Nordsmark M, Eriksen JG, Alsner J & Horsman MR: Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised doubleblind placebo-controlled trial. Lancet Oncol.  E-publ. 30 August 2005.